New MRI scan and blood tests to find early signs of pancreatic cancer in people with IPMN
Part of Cancer, Digestive system clinical trials.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a pancreatic cyst that is considered high risk and needs to be removed by surgery.
- You do not have pancreatic cancer already.
- You are not pregnant or breastfeeding.
- You are able to lie flat and tolerate an MRI scan (no severe anxiety or claustrophobia).
- Your liver and kidney function must be within safe limits, and you must not have serious heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
Hear when a new Pancreatic Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.